Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2019-04-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于可转换公司债券2019年跟踪信用评级报告的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the 2019 follow-up credit rating report for a convertible bond issued in 2017 by the company. It references the credit rating agency's report and provides a link to the full report on an external website. The document is short (811 characters) and primarily serves to announce the credit rating update rather than containing the full report or detailed financial data. It does not fit into categories like Annual Report, Interim Report, or Audit Report. It is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about credit rating without the full report attached.
2019-04-25 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 95% confidence The document is titled '2019年第一季度报告正文' which translates to '2019 First Quarter Report'. It contains detailed financial data such as revenue, net profit, cash flow, assets, liabilities, and shareholder information for the first quarter of 2019. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an interim or quarterly report. The document length is 6747 characters, which is sufficient to contain substantive financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-23 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policies related to new financial instrument standards issued by the Ministry of Finance. It details the reasons for the change, the impact on financial statements, and includes opinions from the board, independent directors, and supervisory board. The document is relatively short (3602 characters) and does not contain actual financial statements or detailed financial data. It is a formal announcement of an accounting policy change rather than a full financial report or audit report. It does not fit categories like Annual Report (10-K), Interim Report (IR), or Audit Report (AR). It is not a regulatory certification or officer attestation, so not RNS. The best fit is a Regulatory Filing (RNS) as it is a formal regulatory announcement about accounting policy changes without substantive financial data or report content.
2019-04-23 Chinese
关于第四届监事会第四次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the fourth meeting of the fourth Supervisory Board of 特一药业集团股份有限公司 on April 23, 2019. It includes approval of the company's 2019 first quarter report and changes in accounting policies. The document is relatively short (1200 characters) and primarily serves as a formal announcement of meeting decisions rather than containing the full quarterly report or detailed financial statements. It does not contain comprehensive financial data or analysis itself but confirms the supervisory board's review and approval of the quarterly report and accounting policy changes. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-04-23 Chinese
独立董事关于会计政策变更的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent director's opinion on changes in accounting policies of the company. It references compliance with accounting standards and regulatory requirements but does not contain financial statements or detailed financial data. It is a formal opinion related to governance and regulatory compliance rather than a full audit report or annual report. The document length is short (911 characters), and it is a standalone statement by independent directors regarding accounting policy changes. This fits best under Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, excluding full annual reports. Q1 2019
2019-04-23 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2019年第一季度报告" which translates to "2019 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow information, and management's discussion of financial performance for the first quarter of 2019. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-23 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.